The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

Abstract

The Group support interactions between the industry and clinicians provided that it is transparent and ethical.

Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research: A Joint Journal and Pharmaceutical Industry Perspective

“…1,2 In response, many pharmaceutical companies have integrated best practices and recommendations from groups such as the International Committee of Medical Journal Editors (ICMJE), the Good Publication Practice guidelines, the Committee on Publication Ethics, the EQUATOR (Enhancing the QUAlity and Transparency Of health Resources) Network, and the Medical Publishing Insights and Practices (MPIP) initiative into their internal policies and standard operating procedures. [3][4][5][6][7][8][9][10] However, a credibility gap remains: some observers, including some journal editors and academic reviewers, maintain a persistent negative view of industry-sponsored studies.…”

Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: A policy statement from the European society of cardiology

“…The future probity of medical education in Europe depends on devising legitimate and ethical collaborations between health-care providers, academic institutions, professional associations, charitable foundations, and industry. 25 The ESC advocates a principled and balanced approach that acknowledges disclosures of interest between health-care professionals and industry, and aims to provide honest and unbiased education for healthcare professionals. 40 The goal of CME is to develop, maintain, or increase the knowledge, understanding, procedural skills, and professional performance of physicians, to enable them to provide the highest quality of care for their patients.…”

“…24 Others have suggested that 'competing interests' may be a more helpful indicator of potential bias than 'conflicts of interest' 25 and that only 'significant' relationships might disqualify an individual from particular educational roles. 26 European drug regulatory agencies have determined that although conflicts of interest cannot be eliminated, the risk of bias can be managed.…”

The relationship between paediatric practitioners and ‘industry’

“…The paediatric practitioner's role is to provide the best care for infants, children and adolescents, using current evidence-based knowledge, while making a reasonable living. Industry's role is to provide safe and effective health care products while returning a profit to company shareholders (6). Both practitioners and patients depend on industry to develop new products and bring them to market, and busy practitioners often rely on industry representatives for product information.…”